Healthcare innovation

2022-12-22 | NDAQ:IDXX | Press Release


2022-12-22 | NDAQ:IDXX | Press Release

WESTBROOK, Maine, Dec. 22, 2022 /PRNewswire/ — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023. Jay Mazelsky, President and Chief Executive Officer will participate in a fireside chat at 1:15 pm ET.

Individuals can access the live audio webcast of the presentation through a link on the IDEXX website, An archived edition of the presentation will be available via the same link.

IDEXX Laboratories, Inc. logo. (PRNewsFoto/IDEXX Laboratories, Inc.)

About IDEXX Laboratories, Inc.

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs more than 10,000 people and offers solutions and products to customers in more than 175 countries. For more information about IDEXX, visit

Investor Relations
John Ravis

Cision View original content to download multimedia:

SOURCE IDEXX Laboratories, Inc.


Leave your thought here

Your email address will not be published. Required fields are marked *